| Date Filed | Type | Description |
| 08/14/2023 |
SC 13D/A
| Lundbeckfond Invest A/S reports a 29.6% stake in IO Biotech, Inc. |
| 08/11/2023 |
4
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 7,901,234 shares
@ $1.9, valued at
$15M
Granted 7,901,234 warrants
@ $2.47, valued at
$19.5M
|
|
| 01/26/2022 |
SC 13G/A
| Lundbeckfond Invest A/S reports a 4.5% stake in Trevi Therapeutics, Inc. |
| 01/26/2022 |
SC 13G
| Lundbeckfond Invest A/S reports a 8.3% stake in Reneo Pharmaceuticals, Inc. |
| 01/26/2022 |
SC 13G
| Lundbeckfond Invest A/S reports a 6.9% stake in Aura Biosciences, Inc. |
| 11/19/2021 |
SC 13D
| Lundbeckfond Invest A/S reports a 21.8% stake in IO Biotech, Inc. |
| 11/12/2021 |
4
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Converted 2,014,161 shares
@ $0
Converted 1,892,434 shares
@ $0
Bought 2,142,857 shares
@ $14, valued at
$30M
Converted 219,595 preferred shares
@ $0
Converted 150,534 preferred shares
@ $0 |
|
| 11/04/2021 |
3
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 3 on IO Biotech, Inc. |
| 02/03/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/16/2020 |
4
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Converted 1,245,222 shares
@ $0
Bought 187,500 shares
@ $16, valued at
$3M
Converted 478,749 options to buy
@ $0
Converted 5,470,492 preferred shares
@ $0
Converted 1,894,444 preferred shares
@ $0 |
|
| 03/11/2020 |
3
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 3 on IMARA Inc. |
| 01/31/2020 |
SC 13G/A
| Lundbeckfond Invest A/S reports a 4.6% stake in Spero Therapeutics, Inc. |
| 01/31/2020 |
SC 13G
| Lundbeckfond Invest A/S reports a 6.5% stake in Trevi Therapeutics, Inc. |
| 05/13/2019 |
4
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Converted 776,544 shares
@ $0
Bought 375,000 shares
@ $10, valued at
$3.8M
Converted 6,849,315 preferred shares
@ $0 |
|
| 05/07/2019 |
3
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 3 on Trevi Therapeutics, Inc. |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/21/2017 |
4
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Converted 1,544,858 shares
@ $0
Converted 984,366 shares
@ $0
Bought 654,762 shares
@ $14, valued at
$9.2M
Converted 11,092,383 preferred shares
@ $0
Converted 7,067,945 preferred shares
@ $0 |
|
| 11/16/2017 |
3
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 3 on scPharmaceuticals Inc. |
| 11/01/2017 |
3
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 3 on Spero Therapeutics, Inc. |
| 01/29/2016 |
SC 13G
| Lundbeckfond Invest A/S reports a 0% stake in Celladon Corporation |
| 02/23/2015 |
SC 13G
| Lundbeckfond Invest A/S reports a 7.5% stake in Celladon Corporation |